• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100
Technology
FinanceMerck’s cost cutting pays off as results beat expectations
By Laura LorenzettiOctober 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
FinanceGlaxoSmithKline moving forward with Ebola vaccine
By Laura LorenzettiOctober 22, 2014
Daniel Loeb urges Amgen to split into two companies
FinanceDaniel Loeb urges Amgen to split into two companies
By ReutersOctober 21, 2014
Management
LeadershipThe top 10 best-performing CEOs
By Laura LorenzettiOctober 17, 2014
77993380
FinanceEnd of the road for inversions? Abbvie drops $55 billion Shire bid
By ReutersOctober 16, 2014
Abbvie looks like dropping Shire bid after crackdown on tax inversions
FinanceAbbvie looks like dropping Shire bid after crackdown on tax inversions
By Geoffrey SmithOctober 15, 2014
Valeant Offers to Buy Allergan With Pershing's Support
FinanceValeant seen raising offer for Allergan to clinch deal
By Geoffrey SmithOctober 8, 2014
Berlin Hospital Prepares For Possible Ebola Cases
FeaturesDallas Ebola patient gets experimental drug
By TIMEOctober 7, 2014
Ebola outbreak’s impact on 5 key industries
EnergyEbola outbreak’s impact on 5 key industries
By Benjamin SnyderOctober 3, 2014
511882721
FinanceSalix scraps inversion-based deal to buy Cosmo
By ReutersOctober 3, 2014
International
FinanceAs Ebola spreads, drug companies race to develop treatments
By Laura LorenzettiOctober 2, 2014
Berlin Hospital Prepares For Possible Ebola Cases
FinanceStocks roiled by news of first American Ebola case
By Laura LorenzettiOctober 1, 2014
Johnson & Johnson Products Ahead Of Earnings
FinanceJ&J buys Alios BioPharma to gain access to infant medicine
By Laura LorenzettiSeptember 30, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
FinanceTax inversion target companies hit by U.S. crackdown
By Laura LorenzettiSeptember 23, 2014
Merck pays $17 billion for chemical-maker Sigma-Aldrich
FinanceMerck pays $17 billion for chemical-maker Sigma-Aldrich
By Laura LorenzettiSeptember 22, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
North America
California farmers must destroy 420,000 peach trees after Del Monte closes its canneries and cancels more than $550 million in long-term contractsplaceholder alt text
By Sasha RogelbergMay 7, 2026
Arts & Entertainment
'Blue dot fever' plagues musicians like Post Malone, Meghan Trainor, and Zayn as a growing list of artists cancel tours due to lagging ticket salesplaceholder alt text
By Dave Lozo and Morning BrewMay 7, 2026
Economy
U.S. Treasury will have to borrow $2 trillion this year just to continue functioning—more than $166 billion every monthplaceholder alt text
By Eleanor PringleMay 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.